- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer Of Prostate in New Zealand
Total 9937 results
-
Royal North Shore HospitalRecruitingLocally Recurrent Prostate CancerAustralia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Clovis Oncology, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
KangLaiTe USATerminated
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New JerseyTerminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Terminated
-
Johnson & Johnson Private LimitedWithdrawn
-
Roswell Park Cancer InstituteTerminated
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Yale UniversityCompleted
-
NYU Langone HealthTerminatedProstate CancerUnited States
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
New York Prostate InstituteSanofiUnknownProstate CancerUnited States
-
Maimonides Medical CenterCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Terminated
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityVarian Medical SystemsCompletedBreast Cancer | Prostate CancerUnited States
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
Memorial Sloan Kettering Cancer CenterCompletedMRI | Prostate CancerUnited States
-
SonaCare MedicalUnknownRecurrent Prostate CancerUnited States, Canada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate CancerUnited States, Guam
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Mark SteinRecruitingRecurrent Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Novartis PharmaceuticalsCompletedProstate CancerSaudi Arabia, Taiwan, Korea, Republic of, Lebanon, Brazil, China, New Zealand, Australia, Thailand, Kuwait
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Head and Neck Cancer | Prostate CancerUnited States
-
Stony Brook UniversityProgenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Royal North Shore HospitalCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Department of Veterans Affairs, New JerseyPfizerUnknownA Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerProstate CancerUnited States
-
Department of Veterans Affairs, New JerseySanofi; PfizerUnknownProstate CancerUnited States